The fact
The agreement aims to strengthen its clinical research platform for eye diseases.
Investors welcome this collaboration for its growth potential.
Click the link to read an article on the topic:
The agreement aims to strengthen its clinical research platform for eye diseases.
Investors welcome this collaboration for its growth potential.